Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Matti Aapro

Showing results (71-80 of 237) with videos related to

Pageof 24
Sort By:
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|March 21, 2018
Searching for perfection: further progress in management of chemotherapy-induced nausea and vomiting-CME informationMatti Aapro, Mark Clemons, Lee Schwartzberg, et al.
Biodrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy|March 2, 2018
Correction to: Epoetin Biosimilars in the Treatment of Chemotherapy-Induced Anemia: 10 Years' Experience GainedMatti Aapro, Andriy Krendyukov, Martin Schiestl, et al.
Future Oncology (London, England)|August 26, 2022
Efficacy of the dexamethasone-sparing triplet regimen for preventing cisplatin-induced emesis: a combined analysisLuigi Celio, Erminio Bonizzoni, Elena Montani, et al.
Therapeutic Advances in Medical Oncology|May 17, 2012
Comparative cost efficiency across the European G5 countries of originators and a biosimilar erythropoiesis-stimulating agent to manage chemotherapy-induced anemia in patients with cancerMatti Aapro, Paul Cornes, Diana Sun, et al.
Cancer Treatment Reviews|April 10, 2012
Antiresorptive treatment options and bone health in cancer patients-safety profiles and clinical considerationsPeyman Hadji, Matti Aapro, Luis Costa, et al.
The Oncologist|September 15, 2006
What are the current standards of care and recent developments in the management of breast cancer?David Cameron, Richard Bell, Matti Aapro, et al.
Frontiers in Oncology|July 26, 2021
Improving Outcomes of Chemotherapy: Established and Novel Options for Myeloprotection in the COVID-19 EraGary H Lyman, Nicole M Kuderer, Matti Aapro
European Journal of Cancer Care|April 11, 2019
Treatment patterns and outcomes in patients with non-small cell lung cancer receiving biosimilar filgrastim for prophylaxis of chemotherapy-induced/febrile neutropaenia: Results from the MONITOR-GCSF studyMatti Aapro, Andriy Krendyukov, Nadja Höbel, et al.
The Oncologist|May 13, 2022
Chemotherapy-Induced Neutropenia and Febrile Neutropenia in the US: A Beast of Burden That Needs to Be Tamed?Ralph Boccia, John Glaspy, Jeffrey Crawford, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|January 28, 2019
Timing flexibility of oral NEPA, netupitant-palonosetron combination, administration for the prevention of chemotherapy-induced nausea and vomiting (CINV)Sally Baron-Hay, Matti Aapro, Alberto Bernareggi, et al.
Pageof 24

Showing results (71-80 of 237) with videos related to

Sort By:
Pageof 24
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|March 21, 2018
Searching for perfection: further progress in management of chemotherapy-induced nausea and vomiting-CME informationMatti Aapro, Mark Clemons, Lee Schwartzberg, et al.
Biodrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy|March 2, 2018
Correction to: Epoetin Biosimilars in the Treatment of Chemotherapy-Induced Anemia: 10 Years' Experience GainedMatti Aapro, Andriy Krendyukov, Martin Schiestl, et al.
Future Oncology (London, England)|August 26, 2022
Efficacy of the dexamethasone-sparing triplet regimen for preventing cisplatin-induced emesis: a combined analysisLuigi Celio, Erminio Bonizzoni, Elena Montani, et al.
Therapeutic Advances in Medical Oncology|May 17, 2012
Comparative cost efficiency across the European G5 countries of originators and a biosimilar erythropoiesis-stimulating agent to manage chemotherapy-induced anemia in patients with cancerMatti Aapro, Paul Cornes, Diana Sun, et al.
Cancer Treatment Reviews|April 10, 2012
Antiresorptive treatment options and bone health in cancer patients-safety profiles and clinical considerationsPeyman Hadji, Matti Aapro, Luis Costa, et al.
The Oncologist|September 15, 2006
What are the current standards of care and recent developments in the management of breast cancer?David Cameron, Richard Bell, Matti Aapro, et al.
Frontiers in Oncology|July 26, 2021
Improving Outcomes of Chemotherapy: Established and Novel Options for Myeloprotection in the COVID-19 EraGary H Lyman, Nicole M Kuderer, Matti Aapro
European Journal of Cancer Care|April 11, 2019
Treatment patterns and outcomes in patients with non-small cell lung cancer receiving biosimilar filgrastim for prophylaxis of chemotherapy-induced/febrile neutropaenia: Results from the MONITOR-GCSF studyMatti Aapro, Andriy Krendyukov, Nadja Höbel, et al.
The Oncologist|May 13, 2022
Chemotherapy-Induced Neutropenia and Febrile Neutropenia in the US: A Beast of Burden That Needs to Be Tamed?Ralph Boccia, John Glaspy, Jeffrey Crawford, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|January 28, 2019
Timing flexibility of oral NEPA, netupitant-palonosetron combination, administration for the prevention of chemotherapy-induced nausea and vomiting (CINV)Sally Baron-Hay, Matti Aapro, Alberto Bernareggi, et al.
Pageof 24